Allspring Global Investments’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-87,795	Closed	-$417K	–	2978
2022 Q1	$417K	Buy	87,795 +14,784	+20%	+$70.2K	﹤0.01%	2298
2021 Q4	$266K	Buy	+73,011	New	+$266K	﹤0.01%	2551